Easton Pharmaceuticals Completes Sub-Distribution Agreement With Gedeon Richter

Easton Pharmaceuticals (OTC:EAPH) finalized a sub-distribution agreement with Gedeon Richter Plc and its Mexican subsidiary company for the product AmnioSense.
As quoted in the press release:

AmnioSense Represents Second Product Launch With Gedeon Richter, Initial Deposit Received On First Purchase Order With Launch Expected In September of 2017.
The “AmnioSense” distribution agreement represents the second product launch with Gedeon Richter S.A.P.I. de CV following the successful launch of “Gynofit” in the second quarter of this year. An initial deposit has been forwarded for the first purchase order of “AmnioSense” with delivery of first commercial order set for August and launch of “AmnioSense” set for September.
Evan Karras, CEO of Easton Pharmaceuticals, stated, “We at Easton Pharmaceuticals are extremely pleased to have participated with BMV and our host company Ackerman Pharma, S.A. de C.V. in closing with Gedeon Richter S.A.P.I de C.V. after many months of negotiations for what is now our second product launch after “Gynofit”. The facts are that this is a sought-after product to assist expecting mothers with something that was previously an unknown and required doctor’s visits or unnecessary trips to the hospital.”

Click here to read the full press release.

Source: www.marketwired.com